<DOC>
	<DOCNO>NCT00239785</DOCNO>
	<brief_summary>This study evaluate safety efficacy FTY720 combine cyclosporine corticosteroid patient receive kidney organ transplant</brief_summary>
	<brief_title>Efficacy Safety FTY720 de Novo Adult Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Inclusion Criteria Male female patient race 18 65 year old ( inclusive ) Patients schedule undergo primary cadaveric primary nonHLA identical living donor kidney transplantation Patients give write informed consent participate study Exclusion Criteria Recipients multiorgan transplantation foreseen receive nonrenal allograft study period Graft cold ischemia time great 40 hour . Patients pulse rate &lt; 50 beat per minute ( bpm ) screen Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Transplantation , kidney , organ transplant .</keyword>
</DOC>